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Sir, 26 
 27 
Since 2000, extended-spectrum β-lactamase (ESBL) producing bacteria have increasingly 28 
been detected in humans and animals. Their impact on human health has drawn much 29 
attention worldwide. Many reports exist about the diversity of ESBLs among 30 
Enterobacteriaceae from food-producing animals 1. Also for companion animals, several 31 
studies have been described 1. Recently some surveys have suggested that European wild 32 
birds may act as reservoirs of resistant bacteria 2 and might have an epidemiological role in 33 
the dissemination of resistance. Therefore, to gain more insight in the role of migratory birds 34 
as reservoir in this, a large population of wild geese in Belgium was screened for the presence 35 
of ceftiofur resistant Escherichia coli (E. coli). 36 
For this purpose, cloacal swabs from 396 wild geese (354 Branta canadensis and 42 wild 37 
Anser anser domesticus) originating from 6 wildlife areas in Belgium were collected and 38 
within 4 hours inoculated on MacConkey agar plates (Oxoid LTD, Basingstoke, Hampshire, 39 
England) supplemented with ceftiofur (8 mg/L). After overnight aerobic incubation at 37°C, 40 
suspected E. coli colonies were purified on Columbia agar with 5% sheep blood (blood agar, 41 
Oxoid) and phenotypically identified 3. To confirm resistance against the β-lactams, the 42 
antimicrobial susceptibility of the E. coli isolates against ampicillin (10 µg), ceftiofur (30 µg) 43 
and amoxicillin-clavulanic acid (20 + 10 µg) (Neo-sensitabs, Rosco Diagnostica, Taastrup, 44 
Denmark) was determined using the disk diffusion test according to the guidelines of the 45 
Clinical Laboratory Standards Institute (CLSI, 2008) 4. The β-lactamases of the cultured E. 46 
coli were characterized by performing polymerase chain reaction (PCR) for detection of genes 47 
encoding TEM-, SHV-, CTX-M- and CMY- type enzymes as previously described 5,6. To 48 
establish the clonal relationship between the E. coli isolates, multilocus sequence analysis 49 
(MLST) using seven conserved housekeeping genes (adk, fumC, gyrB, icd, mdh, purA and 50 
recA) (http://mlst.ucc.ie) was performed 7. All PCR products were purified using a 51 
Nucleospin Extract II kit (Marchery-Nagel GmbH & Co. KG, Düren) and sequenced using 52 
GeneAmp PCR 9700 Applied Biosystems sequencer (Foster City, USA). For sequencing, the 53 
PCR primers were used. The obtained nucleotide sequences were compared with those 54 
previously described for bla genes (BLAST database: http://www.ncbi.nlm.nih.gov/BLAST/). 55 
From the 396 faecal samples, 2 ceftiofur resistant E. coli isolates were obtained. The isolates 56 
originated from geese of the same wildlife area (Donkmeer, Berlare). Characterisation and 57 
sequencing of the genes encoding the β-lactamases showed that the first E. coli isolate, 58 
originating from a Canada goose (Branta canadensis), carried a blaSHV gene encoding ESBL 59 
SHV-12. The sequence type of the E. coli isolate after MLST analysis corresponded to ST 60 
1079. The second isolate, originating from a wild domestic goose (Anser anser domesticus), 61 
was found to carry a blaTEM gene encoding ESBL TEM-52. This isolate was assigned to ST 62 
1844. 63 
The population of wild domestic and Canada geese in Belgium is estimated at 10000 birds 8. 64 
Since 396 wild geese were swabbed, approximately 4% of the total Belgian population was 65 
included in the study. ESBL producing E. coli were only isolated out of 2 geese (0.5% of the 66 
sampled animals). Analysis of the ESBL profile of the two ceftiofur resistant E. coli isolates 67 
in this study resulted in the identification of the genes TEM-52 and SHV-12. These genes are 68 
often present in ceftiofur resistant E. coli from poultry, cattle, pigs and humans 1. The 69 
sequence types of the two E. coli isolates already existed in the MLST Database 70 
(http://mlst.ucc.ie). ST 1079 was previously isolated from a bovine that died because of extra- 71 
intestinal pathogenic E. coli (ExPEC) septicaemia in the United Kingdom.  ST 1844 was 72 
isolated from a healthy human in France. This demonstrates that the MLST-types found in the 73 
geese are not restricted to wild birds.  74 
In conclusion, although the role of wild geese as a reservoir of bacteria carrying ESBL 75 
encoding genes seems to be limited at present, the results of this study may indicate that these 76 
resistance determinants have disseminated in the natural environment.  77 
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